Literature DB >> 12773926

[Therapeutics indications and prognosis of eclampsia at Dakar University Teaching Hospital].

C-T Cissé1, M-E Faye Dieme, D Ngabo, M Mbaye, P-M Diagne, J-C Moreau.   

Abstract

OBJECTIVE: To study the factors of risk of complications and evaluate the quality of medical and obstetrical management of eclampsia.
METHODOLOGY: We performed a retrospective analysis of all cases of eclampsia recorded during the ante- or per partum period from January 1, 2000 to December 31, 2001 at the gynecological and obstetrical clinic at Dakar University Teaching Hospital.
RESULTS: Eclampsia had concerned 78 patients, with an incidence of 8 per 1000 childbirth. The epidemiological profile was primipara (68%), young (average age: 20 years), 36 weeks pregnancy or more (60,3%), evacuation in a state of post critical coma (74.3%), on average after 2 seizures, without medical assistance (64%) with an average diastolic blood pressure of 100 mm Hg. Examinations with strong prognosis value like blood count, creatininemia, coagulation, hepatic transaminases and uricemia were not available in emergency (only 24% of all cases). Medicines prescribed included, nicardipine (63%) and magnesia sulfate (53%); this medical treatment was satisfactory in 34.6% of the cases. Cesarean section was performed in 50%. The prognosis was marked by 17.9% maternal mortality and a perinatal mortality of 359 per 1000 births. The principal risk factors of maternal and perinatal complications were early-onset eclampsia, large number of seizures and late obstetrical treatment.
CONCLUSION: Prehospital treatment and availability of early cesarean section must be better organized to improve the prognosis of eclampsia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773926

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  1 in total

1.  [Epidemiological profile and management of eclampsia in Senegal: about 62 cases].

Authors:  Abdoul Aziz Diouf; Moussa Diallo; Magatte Mbaye; Sokhna Diarra Sarr; Marie Edouard Faye-Diémé; Jean Charles Moreau; Alassane Diouf
Journal:  Pan Afr Med J       Date:  2013-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.